Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | FLT4 |
| Gene Name: | FLT4 |
| Protein Full Name: | Vascular endothelial growth factor receptor 3 |
| Alias: | EC 2.7.1.112; EC 2.7.10.1; FLT4; Fms-related tyrosine kinase 4; PCL; Tyrosine-protein kinase receptor FLT4; VEGFR3; VGFR3; VGR3 |
| Mass (Da): | 145599 |
| Number AA: | 1298 |
| UniProt ID: | P35916 |
| Locus ID: | 2324 |
| COSMIC ID: | FLT4 |
| Gene location on chromosome: | 5q35.3 |
| Cancer protein type: | OP |
| Effect of cancer mutation on protein: | GAIN |
| Effect of active protein on cancer: | PROMOTES |
| Number of cancer specimens: | 20779 |
| Percent of cancer specimens with mutations: | 1.5 |
| Normal role description: | FLT4 is a receptor-tyrosine kinase that is activated upon binding vascular endothelial growth factor. |